• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cryo-Cell International, Inc. - Common Stock (NY:CCEL)

    3.480 +0.580 (+20.00%)
    Streaming Delayed Price Updated: 11:04 AM EDT, Jun 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cryo-Cell International, Inc. - Common Stock

    News headline image
    Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cryo-Cell Receives NYSE American Continued Listing Notice
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Looking Into Cryo-Cell International's Return On Capital Employed ↗
     
    Via Benzinga
    News headline image
    Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cryo-Cell International, Inc. Provides Dividend Update
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    CCEL Stock Earnings: Cryo-Cell International Beats EPS, Beats Revenue for Q2 2024 ↗
    CCEL stock results show that Cryo-Cell International beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    CCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024 ↗
    CCEL stock results show that Cryo-Cell International beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results
    From Cryo-Cell International, Inc.
    Via Business Wire
    News headline image
    Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday ↗
       Losers 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Gainers 
    Via Benzinga
    News headline image
    Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗
    Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy. 
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.